NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseClifford R. Jack, Nina Silverberg, David A. Bennett et al.|Alzheimer s & Dementia|2018Cited by 10.4k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's DiseaseSamantha Budd Haeberlein, Alfred Sandrock, Gersham Dent et al.|The Journal of Prevention of Alzheimer s Disease|2022Cited by 1.3k
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseStephen Salloway, Karen Smirnakis, Spyros Chalkias et al.|JAMA Neurology|2021Cited by 590